首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到5条相似文献,搜索用时 0 毫秒
1.
2.
Reasons for performing the study: Platelet‐rich plasma (PRP) is increasingly used for treatment of orthopaedic injuries. However, the effects of different stimuli on the release pattern of regenerative and proinflammatory factors from equine platelets are largely unknown and an optimal treatment protocol remains to be established. Objectives: The aim of this study was to identify a stimulus that enhanced release of histopromotive factors (platelet‐derived growth factor BB [PDGF] and transforming growth factor 1β[TGF]) without causing concurrent release of a proinflammatory mediator (CCL5). Methods: Washed platelets were prepared from 6 healthy ponies and release of growth factors and CCL5 measured using commercially available ELISAs for human proteins following incubation with or without thrombin, chitosan or equine recombinant tumour necrosis factor (erTNF) over 24 h and subsequently over 96 h. Additionally, noncoagulated samples were analysed. Results: Regardless of whether a stimulus was present or what stimulus was used, PDGF and TGF release was maximal by 0.5–1 h when clot formation took place and very little release was observed after 24 h. Growth factor release was minimal in noncoagulated samples. In contrast, CCL5 release was not associated with coagulation and appeared to persist for much longer. High concentrations of erTNF caused significantly greater release of CCL5 at 6 h than any other stimulus tested. Conclusions: Growth factor release from equine platelets is dependent on coagulation but independent of the initiating stimulus, and is accompanied by more sustained release of proinflammatory mediators. Potential relevance: Supernatants collected from coagulated platelets could be an alternative treatment to PRP.  相似文献   

3.
REASONS FOR PERFORMING STUDY: Suspensory ligament (SL) desmitis is a common source of lameness. The results of this study will determine if blood-derived products stimulate SL matrix synthesis and have potential as regenerative therapies for SL desmitis OBJECTIVES: To determine if various blood-based biological products including plasma, blood, PRP, platelet poor plasma (PPP) and ABM aspirate stimulates anabolic and/or catabolic pathways in suspensory ligaments (SL). METHODS: The body of the SL was harvested from 6 horses and used to establish explant cultures. Explants were cultured in plasma, blood, PRP, PPP or ABM at concentrations of 10, 50 or 100%. Anabolic responses were assessed by use of quantitative PCR for collagens type I and III, cartilage oligomeric matrix protein (COMP) and decorin. Total DNA and collagen protein content were also measured. Catabolic reactions were measured by quantitative PCR for matrix metalloproteinases 3 and 13 (MMP-3, MMP-13). Results: Acellular bone marrow aspirate at 100% stimulated decorin and COMP mRNA synthesis more than all other treatments at all concentrations. No treatment at any concentration stimulated the catabolic gene MMP-13; only 50% ABM stimulated MMP-13 mRNA expression. CONCLUSIONS: Acellular bone marrow is indicated, and might be preferred to plasma, blood or PPP, as a blood-based biological source for SL tissue regenerative therapy. Long-term, placebo controlled case studies are indicated to determine if ABM aids in recovery from SL desmitis. POTENTIAL RELEVANCE: Bone marrow aspirate is an autogenous, readily available biological source for SL regenerative therapy where the aim is to stimulate matrix synthesis.  相似文献   

4.
Summary

A Complement Fixation Test (CFT) was developed for the diagnosis of Erysipelas infections. The results of that work were compared with those of the Growth Inhibition Test (GIT), and they showed that the CFT test was very useful to determine whether an animal had been vaccinated or was still suffering from the disease. The CFT is as reliable as the GIT in detecting recent as well as chronic infections, but its value is limited where animals are examined for their response to a vaccination.

The test is quick, easy, and safe to conduct.  相似文献   

5.
The clinical effect of the intra-articular injection of an autologous platelet concentrate (PC) in four horses with osteoarthritis was evaluated. The degree of lameness and joint effusion and clinical follow-up were recorded. Three injections of PC were performed at 2-week intervals. Horses were evaluated before each injection and two months after the last treatment. Clinical follow-up was conducted for 1 year. Count of platelets, leukocytes, and determination of transforming growth factor beta-1 (TGF-β1) levels per milliliter PC were performed, as well as leukocyte count, cytology, and protein levels in synovial fluid. PC produced a statistically significant improvement in both the degree of lameness and joint effusion (P < .05). The most marked improvement was observed 2 months after the last treatment and apparently persisted for 8 months. A mean of 250 ± 71.8 × 106 platelets, 8.68 ± 3.78 leukocytes × 106, and 12,515 ± 2,443 pg of TGF-β1 per milliliter PC were obtained. The evaluated synovial fluid parameters remained between normal values. No adverse clinical signs resulted from this treatment. Despite the seemingly positive effects of this substance, the clinical use of PC cannot be recommended until further studies with higher numbers of cases and longer follow-up can be undertaken.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号